One-year clinical outcomes of different coronary drug eluting stents—Data from a prospective registry

We compared one-year clinical outcomes of different drug eluting stents (DES) used in a prospective observation registry maintained in two hospitals over three years. The primary endpoint was combination of all-cause mortality, stent thrombosis and revascularization. There was no significant differe...

Descripción completa

Detalles Bibliográficos
Autores principales: Sastry, B.K.S., Nallamalla, Krishna Reddy, Kumar, Nirmal, Kodati, Deepti, Menon, Rajeev
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116781/
https://www.ncbi.nlm.nih.gov/pubmed/30170658
http://dx.doi.org/10.1016/j.ihj.2018.05.012
Descripción
Sumario:We compared one-year clinical outcomes of different drug eluting stents (DES) used in a prospective observation registry maintained in two hospitals over three years. The primary endpoint was combination of all-cause mortality, stent thrombosis and revascularization. There was no significant difference among different DES. We grouped DES into well-evaluated Imported DES (Imported group), which used to be expensive prior to price control and economical Indian DES (Indigenous group) that lack supportive clinical trials. One-year follow-up data was available in 99% of Indigenous group (n=1856) and 98.5% of Imported group (n = 1539). After propensity score matching, there were 1310 matched pairs. There was no significant difference between two groups in the primary end-point or each of the components.

Ejemplares similares